LANXESS AG (LXS.DE) Stock Fundamental Analysis

FRA:LXS • DE0005470405

19.12 EUR
-0.24 (-1.24%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LXS. LXS was compared to 69 industry peers in the Chemicals industry. The financial health of LXS is average, but there are quite some concerns on its profitability. LXS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • LXS had positive earnings in the past year.
  • In the past year LXS had a positive cash flow from operations.
  • LXS had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years LXS had a positive operating cash flow.
LXS.DE Yearly Net Income VS EBIT VS OCF VS FCFLXS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

  • LXS has a Return On Assets of -2.97%. This is in the lower half of the industry: LXS underperforms 72.46% of its industry peers.
  • LXS has a worse Return On Equity (-6.23%) than 72.46% of its industry peers.
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROIC N/A
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
LXS.DE Yearly ROA, ROE, ROICLXS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • In the last couple of years the Operating Margin of LXS has declined.
  • LXS's Gross Margin of 20.52% is on the low side compared to the rest of the industry. LXS is outperformed by 72.46% of its industry peers.
  • In the last couple of years the Gross Margin of LXS has declined.
  • The Profit Margin and Operating Margin are not available for LXS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.52%
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
LXS.DE Yearly Profit, Operating, Gross MarginsLXS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

4

2. Health

2.1 Basic Checks

  • LXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, LXS has about the same amount of shares outstanding.
  • Compared to 5 years ago, LXS has more shares outstanding
  • Compared to 1 year ago, LXS has an improved debt to assets ratio.
LXS.DE Yearly Shares OutstandingLXS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXS.DE Yearly Total Debt VS Total AssetsLXS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • LXS has an Altman-Z score of 1.91. This is not the best score and indicates that LXS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • LXS has a Altman-Z score of 1.91. This is in the lower half of the industry: LXS underperforms 65.22% of its industry peers.
  • The Debt to FCF ratio of LXS is 22.13, which is on the high side as it means it would take LXS, 22.13 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 22.13, LXS perfoms like the industry average, outperforming 49.28% of the companies in the same industry.
  • A Debt/Equity ratio of 0.62 indicates that LXS is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.62, LXS is doing worse than 62.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Altman-Z 1.91
ROIC/WACCN/A
WACC4.63%
LXS.DE Yearly LT Debt VS Equity VS FCFLXS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.60 indicates that LXS has no problem at all paying its short term obligations.
  • The Current ratio of LXS (2.60) is better than 78.26% of its industry peers.
  • A Quick Ratio of 1.29 indicates that LXS should not have too much problems paying its short term obligations.
  • LXS has a Quick ratio of 1.29. This is in the better half of the industry: LXS outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 1.29
LXS.DE Yearly Current Assets VS Current LiabilitesLXS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

1

3. Growth

3.1 Past

  • The earnings per share for LXS have decreased strongly by -10.28% in the last year.
  • The earnings per share for LXS have been decreasing by -19.38% on average. This is quite bad
  • LXS shows a decrease in Revenue. In the last year, the revenue decreased by -6.82%.
  • Measured over the past years, LXS shows a decrease in Revenue. The Revenue has been decreasing by -1.32% on average per year.
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%

3.2 Future

  • Based on estimates for the next years, LXS will show a decrease in Earnings Per Share. The EPS will decrease by -1.11% on average per year.
  • The Revenue is expected to decrease by -0.69% on average over the next years.
EPS Next Y-79.53%
EPS Next 2Y-37.05%
EPS Next 3Y-8.29%
EPS Next 5Y-1.11%
Revenue Next Year-10.25%
Revenue Next 2Y-5.69%
Revenue Next 3Y-2.95%
Revenue Next 5Y-0.69%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LXS.DE Yearly Revenue VS EstimatesLXS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
LXS.DE Yearly EPS VS EstimatesLXS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 19.92 indicates a rather expensive valuation of LXS.
  • Compared to the rest of the industry, the Price/Earnings ratio of LXS indicates a somewhat cheap valuation: LXS is cheaper than 62.32% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.10. LXS is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 30.54, LXS can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, LXS is valued a bit more expensive than the industry average as 65.22% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. LXS is around the same levels.
Industry RankSector Rank
PE 19.92
Fwd PE 30.54
LXS.DE Price Earnings VS Forward Price EarningsLXS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, LXS is valued cheaply inside the industry as 82.61% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of LXS indicates a rather cheap valuation: LXS is cheaper than 85.51% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.74
EV/EBITDA 6.31
LXS.DE Per share dataLXS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • LXS's earnings are expected to decrease with -8.29% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-37.05%
EPS Next 3Y-8.29%

0

5. Dividend

5.1 Amount

  • LXS has a yearly dividend return of 0.52%, which is pretty low.
  • Compared to an average industry Dividend Yield of 2.25, LXS is paying slightly less dividend.
  • With a Dividend Yield of 0.52, LXS pays less dividend than the S&P500 average, which is at 1.83.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

  • The dividend of LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr Years0
Div Non Decr Years1
LXS.DE Yearly Dividends per shareLXS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • LXS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The Dividend Rate of LXS has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-4.12%
EPS Next 2Y-37.05%
EPS Next 3Y-8.29%
LXS.DE Yearly Income VS Free CF VS DividendLXS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

LANXESS AG

FRA:LXS (2/27/2026, 7:00:00 PM)

19.12

-0.24 (-1.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06
Earnings (Next)03-19
Inst Owners73.38%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap1.65B
Revenue(TTM)5.89B
Net Income(TTM)-243.00M
Analysts55
Price Target19.72 (3.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-4.12%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)292.85%
Min EPS beat(2)79.47%
Max EPS beat(2)506.23%
EPS beat(4)4
Avg EPS beat(4)279.29%
Min EPS beat(4)79.47%
Max EPS beat(4)506.23%
EPS beat(8)8
Avg EPS beat(8)234.01%
EPS beat(12)11
Avg EPS beat(12)164.45%
EPS beat(16)14
Avg EPS beat(16)126.78%
Revenue beat(2)0
Avg Revenue beat(2)-8.07%
Min Revenue beat(2)-8.49%
Max Revenue beat(2)-7.66%
Revenue beat(4)0
Avg Revenue beat(4)-5.7%
Min Revenue beat(4)-8.49%
Max Revenue beat(4)-1.78%
Revenue beat(8)1
Avg Revenue beat(8)-4.92%
Revenue beat(12)2
Avg Revenue beat(12)-4.05%
Revenue beat(16)3
Avg Revenue beat(16)-5.05%
PT rev (1m)-0.56%
PT rev (3m)-13.12%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)2.04%
EPS NY rev (1m)0%
EPS NY rev (3m)-32.19%
Revenue NQ rev (1m)-1.94%
Revenue NQ rev (3m)-4.01%
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 19.92
Fwd PE 30.54
P/S 0.28
P/FCF 14.74
P/OCF 3.82
P/B 0.42
P/tB 0.98
EV/EBITDA 6.31
EPS(TTM)0.96
EY5.02%
EPS(NY)0.63
Fwd EY3.27%
FCF(TTM)1.3
FCFY6.78%
OCF(TTM)5
OCFY26.17%
SpS68.19
BVpS45.2
TBVpS19.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.25
Profitability
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.52%
FCFM 1.9%
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Debt/EBITDA 4.55
Cap/Depr 50.71%
Cap/Sales 5.43%
Interest Coverage N/A
Cash Conversion 81.82%
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 1.29
Altman-Z 1.91
F-Score6
WACC4.63%
ROIC/WACCN/A
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
EPS Next Y-79.53%
EPS Next 2Y-37.05%
EPS Next 3Y-8.29%
EPS Next 5Y-1.11%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%
Revenue Next Year-10.25%
Revenue Next 2Y-5.69%
Revenue Next 3Y-2.95%
Revenue Next 5Y-0.69%
EBIT growth 1Y82.42%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1016.78%
EBIT Next 3Y136.04%
EBIT Next 5Y73.07%
FCF growth 1Y-74.13%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y-44.97%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%

LANXESS AG / LXS.DE FAQ

Can you provide the ChartMill fundamental rating for LANXESS AG?

ChartMill assigns a fundamental rating of 3 / 10 to LXS.DE.


Can you provide the valuation status for LANXESS AG?

ChartMill assigns a valuation rating of 4 / 10 to LANXESS AG (LXS.DE). This can be considered as Fairly Valued.


What is the profitability of LXS stock?

LANXESS AG (LXS.DE) has a profitability rating of 2 / 10.


Can you provide the financial health for LXS stock?

The financial health rating of LANXESS AG (LXS.DE) is 4 / 10.


What is the expected EPS growth for LANXESS AG (LXS.DE) stock?

The Earnings per Share (EPS) of LANXESS AG (LXS.DE) is expected to decline by -79.53% in the next year.